Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation.Published in:Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49486-5By:Nacev, Benjamin A.;Dabas, Yakshi;Paul, Matthew R.;Pacheco, Christian;Mitchener, Michelle;Perez, Yekaterina;Fang, Yan;Soshnev, Alexey A.;Barrows, Douglas;Carroll, Thomas;Socci, Nicholas D.;St. Jean, Samantha C.;Tiwari, Sagarika;Gruss, Michael J.;Monette, Sebastien;Tap, William D.;Garcia, Benjamin A.;Muir, Tom;Allis, C. DavidPublication type:Article